University of California San Francisco
Give to UCSF
A natural form of sugar could offer a noninvasive way to precisely image tumors and determine whether cancer medication is effective using new technology developed at UCSF in collaboration with GE Healthcare.
UCSF’s Emmanuelle Passegué, an expert on how the blood system arises during development, recently led a study in which researchers discovered how leukemia, a blood cancer, can gain a stronghold in bone marrow and inhibit the development of normal immune cells.
A group of scientists convened by the National Cancer Institute and chaired by a UCSF breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
Stem-cell researchers at UCSF have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
UCSF researchers have found a way to knock down cancers caused by a tumor-driving protein called “myc,” paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.
Aspirin is known to lower risk for some cancers, and a new UCSF-led study points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
